VRTX has recorded a positive one-day return after earnings in 58% of instances. When the return is positive, the median ...

Does Earnings Surprise History Hold Any Clue ... Should You Invest in Vertex Pharmaceuticals Incorporated (VRTX)? Before you invest in Vertex Pharmaceuticals Incorporated (VRTX), want to know ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

"It is not some Disney story of just triumph and resilience, it was really hard," Smith tells PEOPLE about his recovery ...

The market expects Vertex Pharmaceuticals (VRTX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known ...

CRISPR Therapeutics' revenue streams currently rely heavily on grants and collaboration revenues from its partnership with Vertex Pharmaceuticals (VRTX). The collaboration has yielded Casgevy, a ...

It later moved into medicines, commercialising aspirin around the turn of the 20th century, one of the most successful pharmaceuticals ... And firms such as Vertex have added to the controversy ...

Analysts anticipate Vertex Pharmaceuticals to report an earnings per share (EPS) of $4.31. Anticipation surrounds Vertex Pharmaceuticals's announcement, with investors hoping to hear about both ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...

The stock's fall snapped a seven-day winning streak.